Anti-angiogenic therapy is an old method to fight cancer that aims to abolish the nutrient and
oxygen supply to the tumor cells through the decrease of the vascular network and the …

This is the first clinical practice guideline (CPG) from the American Academy of Pediatrics
(AAP) regarding the management of infantile hemangiomas (IHs). Similar consensus …

Background Oral propranolol has been used to treat complicated infantile hemangiomas,
although data from randomized, controlled trials to inform its use are limited. Methods We …

Infantile hemangiomas (IHs) are common neoplasms composed of proliferating endothelial-
like cells. Despite the relative frequency of IH and the potential severity of complications …

Infantile haemangiomas (IH) are the most common benign tumours of infancy. Although
most IH are innocuous and 85–90% regress spontaneously, some may become life‐or …

Infantile hemangiomas (IHs) are the most common tumors of childhood. Unlike other tumors,
they have the unique ability to involute after proliferation, often leading primary care …

METHODS: We searched Embase and Medline databases (2007–July 2014) and
unpublished data from the manufacturer of Hemangiol/Hemangeol (marketed pediatric …

OBJECTIVE: Propranolol hydrochloride is a safe and effective medication for treating
infantile hemangiomas (IHs), with decreases in IH volume, color, and elevation. METHODS …

To systematically review the literature evaluating efficacy and adverse events of propranolol
treatment for infantile hemangiomas, we searched the MEDLINE and Cochrane databases …

Vascular anomalies include a heterogeneous group of disorders that are categorized as
vascular tumors or vascular malformations. Treatment options include resection …